Omega-3 fatty acid supplement
Omega-3 fatty acid supplement is a dietary supplement with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Altering Lipids for Tolerance of Aromatase Inhibitor Therapy
COVID-19 Anosmia Study
Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole
Omega-3 Fatty Acids as Adjunctive Treatment for Adolescents With Eating Disorders
A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
Clinical Trials (6)
Altering Lipids for Tolerance of Aromatase Inhibitor Therapy
COVID-19 Anosmia Study
Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole
Omega-3 Fatty Acids as Adjunctive Treatment for Adolescents With Eating Disorders
A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
Treating Depression in Coronary Artery Disease With Omega-3 Fatty Acids
All 6 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 6